@ARTICLE{
author={Stanimirovic Violeta V,Nikolic Aleksandra T,Nikolic Dejan V,Stanimirovic Bojan,Stanimirovic B},
year={2013},
title={"Brilique/Ticagrelor/Safety Profile related to threshold of Toxicological concern/TTC/for impurities Ul127, Ul133, Ul134 and Ul 111 major objections of evaluation documentation for granting MA procedure by Medicines and Medical Devices Agency of Serbia-ALIMS},
journal={PROCEEDINGS OF THE 6TH EUROPEAN CONGRESS OF PHARMACOLOGY},
volume={},
number={},
pages={181-183},
document_type={Proceedings Paper},
} 

@ARTICLE{
author={Stanimirovic Violeta V,Nikolic Dejan V,Nikolic Aleksandra T,Stanimitovic B,Stanimirovic B},
year={2013},
title={Safety assessment reevaluation of Biotechnology-Derived Pharmaceuticals as the imperative for getting renewed Marketing Authorisation Approval (MAA) Experience from Medicies and Medical Devices Agency of Serbia-Alims},
journal={PROCEEDINGS OF THE 6TH EUROPEAN CONGRESS OF PHARMACOLOGY},
volume={},
number={},
pages={177-180},
document_type={Proceedings Paper},
} 

@ARTICLE{
author={Stanimirovic Violeta V,Nikolic Dejan V,Nikolic Aleksandra T,Stanimitovic B,Stanimirovic B},
year={2013},
title={"Regulatory dilemma" of ongoing safety review of drug Gilenya (R) (fingolimod)-expierence from Medicines and Medical Devices Agency of Serbia-ALIMS},
journal={PROCEEDINGS OF THE 6TH EUROPEAN CONGRESS OF PHARMACOLOGY},
volume={},
number={},
pages={169-171},
document_type={Proceedings Paper},
} 

@ARTICLE{
author={Stanimirovic Violeta V,Djakovic-Svajcer Kornelija,Solarevic T,Mikov Momir M,Cebedzic Rajko,Stanimirovic B},
year={2009},
title={Clinical pharmacology (cp) vs. pharmaceutical medicine (pm) experience from serbia},
journal={BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY},
volume={105},
number={},
pages={22-22},
document_type={Meeting Abstract},
}